The Senate last night voted 92-2 to approve the conference report to the Comprehensive Addiction and Recovery Act (S. 524), legislation designed to help stem the epidemic of opioid abuse through education, prevention, treatment and rehabilitation. The bill incorporates several key AHA-endorsed measures, including the creation of a multi-agency task force with a hospital representative that will develop best practices for prescribing and pain management; more stringent pre-market review of new opioids by the Food and Drug Administration; increased access to opioid overdose reversal drugs and medication-assisted treatment; and expanded research and treatment for vulnerable populations. The House passed the conference report last week and President Obama is expected to sign it into law. AHA members today received a Special Bulletin with more on the legislation, as well as recent actions by the administration and AHA to combat the opioid abuse epidemic. 

Headline
The Centers for Medicare & Medicaid Services Nov. 5 proposed changes to Medicare’s Conditions of Participation and other administrative requirements that…
Headline
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029. The…
Headline
Federal agencies Nov. 5 issued a bulletin saying that they are aware of malicious cyber activity targeting industrial refrigeration and cold chain monitoring…
Headline
The U.S. District Court for the Eastern District of Pennsylvania Nov. 4 ruled in favor of Jefferson Health in granting a public resolution to determine the…
Headline
The departments of Labor, Health and Human Services, and the Treasury announced yesterday the denial of the recertification of two entities currently…
Headline
Christine Moutier, M.D., chief medical officer at the American Foundation for Suicide Prevention, discusses the usage of artificial intelligence chatbots among…